Gilead’s Trodelvy Redefines TNBC Treatment Paradigm with Groundbreaking Progression-Free Survival Data
Transformative Results in Triple-Negative Breast Cancer Treatment Gilead Sciences has unveiled groundbreaking clinical trial results demonstrating that Trodelvy (sacituzumab govitecan)…
